United Kingdom· GB-APID-39334111000001108
Allergy Relief 8mg capsules
A acrivastine product containing acrivastine, registered in United Kingdom by Brown & Burk UK Ltd. The same ATC class is registered in 4 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Acrivastine is registered in 4 of 19 countries.
Countries holding a registration under ATC R06AX18 (acrivastine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Acrivastine · ATC R06AX18
4 / 19 countries
- Denmark
- Finlandprice
- Netherlands
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Acrivastine
- Manufacturer
- Brown & Burk UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- R06AX18
- ATC class
- Acrivastine
- Defined daily dose
- 24 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5060124641522
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
156 interactions on record for acrivastine.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Acrivastine · interactions on record
156 records
- 8 severe
- 146 moderate
- 2 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- Sodium oxybateN01AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Acrivastine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandBenadrylMcNeil / JNTL Consumer Health (Finland) Oy
- NetherlandsSemprex 8 mg, capsules, hardACE Pharmaceuticals B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Denmark · Allergone, Benadryl
- Finland · Benadryl
- Netherlands · Semprex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3b5cb85-54af-4c77-8f02-80eb46223afe GET /v1/drugs/d3b5cb85-54af-4c77-8f02-80eb46223afe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39334111000001108",
"desc": "Allergy Relief 8mg capsules (Brown & Burk UK Ltd)",
"form": "Oral capsule",
"vpid": "42184011000001104",
"source": "dmd",
"vtm_id": "774431006",
"strength": "8 mg",
"substance": "Acrivastine",
"ingredient": "Acrivastine",
"supplier_code": "32392811000001109"
}See everything about acrivastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.